BioCentury
ARTICLE | Company News

Isotechnika Inc., Atrium Medical deal

October 10, 2005 7:00 AM UTC

Atrium received an exclusive worldwide license to develop and commercialize ISA's TAFA93 and ISA247 compounds with drug-eluting devices for the non-systemic treatment of vascular, cardiovascular, ta...